The Estrogen Receptor Joins Other Cancer Biomarkers as a Predictor of Outcome

• Asıl Yazarlar: Kimberly K. Leslie (Yazar), Kristina W. Thiel (Yazar), Henry D. Reyes (Yazar), Shujie Yang (Yazar), Yuping Zhang (Yazar), Matthew J. Carlson (Yazar), Nirmala S. Kumar (Yazar), Donghai D. Dai (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Hindawi Limited, 2013-01-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Endometrial cancer, the most common gynecologic malignancy in the United States, is on the rise, and survival is worse today than 40 years ago. In order to improve the outcomes, better biomarkers that direct the choice of therapy are urgently needed. In this review, we explore the estrogen receptor...